121 related articles for article (PubMed ID: 21188328)
1. Thrombocytopenia in chronic hepatitis C.
Olariu M; Olariu C; Olteanu D
J Gastrointestin Liver Dis; 2010 Dec; 19(4):381-5. PubMed ID: 21188328
[TBL] [Abstract][Full Text] [Related]
2. Further insights into the causes of thrombocytopenia in chronic hepatitis C.
Giannini EG; Savarino V
J Gastrointestin Liver Dis; 2010 Dec; 19(4):357-8. PubMed ID: 21188322
[No Abstract] [Full Text] [Related]
3. [Autoimmune thrombocytopenia in chronic liver disease].
Panasiuk A; Zak J
Pol Merkur Lekarski; 2001 Dec; 11(66):487-90. PubMed ID: 11899844
[TBL] [Abstract][Full Text] [Related]
4. Thrombocytopenia in patients with chronic hepatitis C: a possible role of HCV on platelet progenitor cell maturation.
El Barbary MA; Saad AE; Attia FM; Mandour MI; Haidara MA; Dallak MM; Isenovic ER
Angiology; 2010 Apr; 61(3):304-13. PubMed ID: 19689996
[TBL] [Abstract][Full Text] [Related]
5. Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C.
Villa E; Karampatou A; Cammà C; Di Leo A; Luongo M; Ferrari A; Petta S; Losi L; Taliani G; Trande P; Lei B; Graziosi A; Bernabucci V; Critelli R; Pazienza P; Rendina M; Antonelli A; Francavilla A
Gastroenterology; 2011 Mar; 140(3):818-29. PubMed ID: 21167831
[TBL] [Abstract][Full Text] [Related]
6. Improvement of thrombocytopenia with disappearance of HCV RNA in patients treated by interferon-alpha therapy: possible etiology of HCV-associated immune thrombocytopenia.
Iga D; Tomimatsu M; Endo H; Ohkawa S; Yamada O
Eur J Haematol; 2005 Nov; 75(5):417-23. PubMed ID: 16191092
[TBL] [Abstract][Full Text] [Related]
7. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
Koruk M; Onuk MD; Akçay F; Savas MC
Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study.
Lee MH; Yang HI; Lu SN; Jen CL; Yeh SH; Liu CJ; Chen PJ; You SL; Wang LY; Chen WJ; Chen CJ
J Clin Oncol; 2010 Oct; 28(30):4587-93. PubMed ID: 20855826
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of thrombocytopenia in chronic hepatitis C as evaluated by the immature platelet fraction.
Zucker ML; Hagedorn CH; Murphy CA; Stanley S; Reid KJ; Skikne BS
Int J Lab Hematol; 2012 Oct; 34(5):525-32. PubMed ID: 22708981
[TBL] [Abstract][Full Text] [Related]
10. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
Wu CH; Xu XY; Tian GS; Yu YY
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological, biological and histological characterization of patients with indeterminate third-generation recombinant immunoblot assay antibody results for hepatitis C virus.
Ríos M; Diago M; Rivera P; Tuset C; Cors R; García V; Carbonel P; Gonzalez C
J Viral Hepat; 2006 Mar; 13(3):177-81. PubMed ID: 16475993
[TBL] [Abstract][Full Text] [Related]
12. Preoperative use of romiplostim in thrombocytopenic patients with chronic hepatitis C and liver cirrhosis.
Moussa MM; Mowafy N
J Gastroenterol Hepatol; 2013 Feb; 28(2):335-41. PubMed ID: 22849409
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of HCV treatment: who does well and who does not?
Hsu CS; Kao JH
J Gastroenterol Hepatol; 2010 May; 25(5):846-8. PubMed ID: 20546434
[No Abstract] [Full Text] [Related]
14. Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection.
Hsu CS; Liu CH; Liu CJ; Hsu SJ; Chen CL; Hwang JJ; Lai MY; Chen PJ; Chen DS; Kao JH
J Gastroenterol Hepatol; 2010 May; 25(5):970-7. PubMed ID: 20546452
[TBL] [Abstract][Full Text] [Related]
15. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
[TBL] [Abstract][Full Text] [Related]
16. High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease.
Tokita H; Murai S; Kamitsukasa H; Yagura M; Harada H; Takahashi M; Okamoto H
J Med Virol; 2002 Aug; 67(4):501-9. PubMed ID: 12115995
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].
Kim SM; Sohn JH; Kim TY; Roh YW; Eun CS; Jeon YC; Han DS; Oh YH
Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264
[TBL] [Abstract][Full Text] [Related]
18. Thrombocytopenia associated with liver cirrhosis and hepatitis C viral infection: role of thrombopoietin.
Español I; Gallego A; Enríquez J; Rabella N; Lerma E; Hernández A; Pujol-Moix N
Hepatogastroenterology; 2000; 47(35):1404-6. PubMed ID: 11100362
[TBL] [Abstract][Full Text] [Related]
19. The APRI and the RVR.
Snyder N; Petersen JR
J Clin Gastroenterol; 2009; 43(5):500-1. PubMed ID: 19098684
[No Abstract] [Full Text] [Related]
20. Progression of liver fibrosis among injection drug users with chronic hepatitis C.
Wilson LE; Torbenson M; Astemborski J; Faruki H; Spoler C; Rai R; Mehta S; Kirk GD; Nelson K; Afdhal N; Thomas DL
Hepatology; 2006 Apr; 43(4):788-95. PubMed ID: 16557548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
